☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Psoriasis
Galapagos Reports Results of GLPG3667 in P-Ib Study for the Treatment of Psoriasis
July 15, 2021
Dermavant Presents Results of Tapinarof in Two P-III Trials for the Treatment of Psoriasis at AAD2021
April 26, 2021
UCB Reports Results of Bimekizumab in P-III BE SURE Study for Moderate-to-Severe Psoriasis
November 2, 2020
Galapagos Reports First Patients Dosing with GLPG3970 (Toledo Compound) for Psoriasis
September 30, 2020
Bio-Thera Initiates P-I Study of BAT2206 Proposed Biosimilar to Stelara (ustekinumab)
September 4, 2020
Cadila Launches Cadalimab (biosimilar- adalimumab) in India
August 31, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.